loadpatents
Patent applications and USPTO patent grants for Hardee; David J..The latest application filed is for "modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use".
Patent | Date |
---|---|
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20220213041 - Bogdan; Andrew ;   et al. | 2022-07-07 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20220211692 - Hardee; David J. ;   et al. | 2022-07-07 |
Inhibitors Of Tyrosine Kinase 2 Mediated Signaling App 20200255423 - Kind Code | 2020-08-13 |
Inhibitors of tyrosine kinase 2 mediated signaling Grant 10,508,113 - Argiriadi , et al. Dec | 2019-12-17 |
Inhibitors Of Tyrosine Kinase 2 Mediated Signaling App 20190276450 - Argiriadi; Maria A. ;   et al. | 2019-09-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.